Patents by Inventor Desheng Tao

Desheng Tao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9265805
    Abstract: A Chinese traditional medicine composition for prevention and treatment of avian influenza is provided. Its active ingredients are consisted of: herba houttuyniae 21.4 wt. %, Caulis lonicerae japonicae 17.9 wt. %, radix isatidis 14.3 wt. %, male fern rhizome 10.7 wt. %, radix et rhizoma sophorae tonkinensis 7.1 wt. %, radix angelicae dahuricae 7.1 wt. %, rhizoma paridis 7.1 wt. %, herba artemisiae annuae 7.2 wt. %, and rhizoma iridis tectoris 7.2 wt. %. This Chinese traditional medicine composition could be made into any regular medicinal types, for example, oral solutions, tablets, capsules, pellets and injection solution, etc. Modified preparation methods for this Chinese traditional medicine composition, as well as the use of the same in preparation of medicines and health foods for prevention or treatment of avian influenza were also provided in present invention. This Chinese traditional medicine composition could effectively prevent and treat avian influenza.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: February 23, 2016
    Assignee: LIVZON PHARMACEUTICAL GROUP INC.
    Inventors: Desheng Tao, Yongqing Zeng, Hui Cao, Yi Guan
  • Patent number: 8795742
    Abstract: A Chinese traditional medicine composition for prevention and treatment of avian influenza is provided. Its active ingredients are consisted of: herba houttuyniae 21.4 wt. %, Caulis lonicerae japonicae 17.9 wt. %, radix isatidis 14.3 wt. %, male fern rhizome 10.7 wt. %, radix et rhizoma sophorae tonkinensis 7.1 wt. %, radix angelicae dahuricae 7.1 wt. %, rhizoma paridis 7.1 wt. %, herba artemisiae annuae 7.2 wt. %, and rhizoma iridis tectoris 7.2 wt. %. This Chinese traditional medicine composition could be made into any regular medicinal types, for example, oral solutions, tablets, capsules, pellets and injection solution, etc. Modified preparation methods for this Chinese traditional medicine composition, as well as the use of the same in preparation of medicines and health foods for prevention or treatment of avian influenza were also provided in present invention. This Chinese traditional medicine composition could effectively prevent and treat avian influenza.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: August 5, 2014
    Assignee: Livzon Pharmaceutical Group Inc.
    Inventors: Desheng Tao, Yongqing Zeng, Hui Cao, Yi Guan
  • Patent number: 8658171
    Abstract: The present invention provides a humanized anti-TNF monoclonal antibody and the use thereof. The humanized anti-TNF monoclonal antibody significantly reduces the immunogenicity of murine-antibody while retaining the ability of antibody to recognize antigen, compared with conservative mouse chimeric antibody. Therefore, safety of the antibody in clinical applications has been improved.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: February 25, 2014
    Assignee: Livzon Mabpharm Inc.
    Inventors: Baoguo Zhu, Desheng Tao, Bill Nai-Chau Sun, Lee-Hwei King Sun, Ruey Shyan Liou, Cecily Rou-Yun Sun, Qiang Li, Yucai Peng, Jingwei Zhang, Zhenxiang Hu
  • Publication number: 20140023732
    Abstract: Disclosed is a use of a pharmaceutical composition in preparation of anti-enterovirus 71 agents.
    Type: Application
    Filed: December 28, 2011
    Publication date: January 23, 2014
    Applicants: NATIONAL ENGINEERING RESEARCH CENTER FOR MODERNIZATION OF TRADITIONAL CHINESE, LIVZON PHARMACEUTICAL GROUP, INC.
    Inventors: Hui Cao, Yi Guan, Yongqing Zeng, Desheng Tao
  • Publication number: 20120219547
    Abstract: The present invention provides a humanized anti-TNF monoclonal antibody and the use thereof. The humanized anti-TNF monoclonal antibody significantly reduces the immunogenicity of murine-antibody while retaining the ability of antibody to recognize antigen, compared with conservative mouse chimeric antibody. Therefore, safety of the antibody in clinical applications has been improved.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 30, 2012
    Inventors: Baoguo Zhu, Desheng Tao, Bill Nai-Chau Sun, Lee-Hwei King Sun, Ruey Shyan Liou, Cecily Rou-Yun Sun, Qiang Li, Yucai Peng, Jingwei Zhang, Zhenxiang Hu
  • Publication number: 20120093951
    Abstract: The present invention relates to a traditional Chinese medicine composition for preventing and treating swine influenza, preparation method and use thereof. The said traditional Chinese medicine composition is made from Herba Houttuyniae 21.4 wt. %, Caulis Lonicerae Japonicae 17.9 wt. %, Radix Isatidis 14.3 wt. %, Rhizoma Dryopteris Crassirhizomatis 10.7%, Radix et Rhizoma Sophorae Tonkinensis 7.1 wt. %, Radix Angelicae Dahuricae 7.1 wt. %, Rhizoma Paridis 7.1 wt. %, Herba Artemisiae Annuae 7.1 wt. %, and Rhizoma Iridis Tectori 7.1 wt. %.
    Type: Application
    Filed: June 17, 2010
    Publication date: April 19, 2012
    Inventors: Desheng Tao, Yongging Zeng, Hui Cao, Yi Guan
  • Publication number: 20080206374
    Abstract: The invention relates to a composition of Radix Codonopsis and Radix Astragali of which the main component is prepared according to a certain weight ratio of Radix Codonopsis and Radix Astragali. The invention also provides a method of preparing the pharmaceutical composition and its applications in the preparation of an immunoregulator and mediciments for the treatment of ischemic heart diseases and acute lung injury.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 28, 2008
    Inventors: Weihong Xie, Desheng Tao, Chunhan Zhi
  • Publication number: 20080206375
    Abstract: The invention relates to a composition of Radix Codonopsis and Radix Astragali of which the main component is prepared according to a certain weight ratio of Radix Codonopsis and Radix Astragali. The invention also provides a method of preparing the pharmaceutical composition and its applications in the preparation of an immunoregulator and medicaments for the treatment of ischemic heart diseases and acute lung injury.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 28, 2008
    Inventors: Weihong Xie, Desheng Tao, Chunhan Zhi
  • Publication number: 20080166439
    Abstract: A Chinese traditional medicine composition for prevention and treatment of avian influenza is provided. Its active ingredients are consisted of: herba houttuyniae 21.4 wt. %, Caulis lonicerae japonicae 17.9 wt. %, radix isatidis 14.3 wt. %, male fern rhizome 10.7 wt. %, radix et rhizoma sophorae tonkinensis 7.1 wt. %, radix angelicae dahuricae 7.1 wt. %, rhizoma paridis 7.1 wt. %, herba artemisiae annuae 7.2 wt. %, and rhizoma iridis tectoris 7.2 wt. %. This Chinese traditional medicine composition could be made into any regular medicinal types, for example, oral solutions, tablets, capsules, pellets and injection solution, etc. Modified preparation methods for this Chinese traditional medicine composition, as well as the use of the same in preparation of medicines and health foods for prevention or treatment of avian influenza were also provided in present invention. This Chinese traditional medicine composition could effectively prevent and treat avian influenza.
    Type: Application
    Filed: February 14, 2008
    Publication date: July 10, 2008
    Inventors: Desheng TAO, Yongqing ZENG, Hui CAO, Yi GUAN
  • Publication number: 20080131529
    Abstract: A Chinese traditional medicine composition for prevention and treatment of avian influenza is provided. Its active ingredients are consisted of: herba houttuyniae 21.4 wt. %, Caulis lonicerae japonicae 17.9 wt. %, radix isatidis 14.3 wt. %, male fern rhizome 10.7 wt. %, radix et rhizoma sophorae tonkinensis 7.1 wt. %, radix angelicae dahuricae 7.1 wt. %, rhizoma paridis 7.1 wt. %, herba artemisiae annuae 7.2 wt. %, and rhizoma iridis tectoris 7.2 wt. %. This Chinese traditional medicine composition could be made into any regular medicinal types, for example, oral solutions, tablets, capsules, pellets and injection solution, etc. Modified preparation methods for this Chinese traditional medicine composition, as well as the use of the same in preparation of medicines and health foods for prevention or treatment of avian influenza were also provided in present invention. This Chinese traditional medicine composition could effectively prevent and treat avian influenza.
    Type: Application
    Filed: February 14, 2008
    Publication date: June 5, 2008
    Inventors: Desheng TAO, Yongqing ZENG, Hui CAO, Yi GUAN
  • Publication number: 20070172531
    Abstract: A Chinese traditional medicine composition for prevention and treatment of avian influenza is provided. Its activated ingredients are consisted of: herba houttuyniae 21.4 wt. %, Caulis lonicerae japonicae 17.9 wt. %, radix isatidis 14.3 wt. %, male fern rhizome 10.7 wt. %, radix et rhizoma sophorae tonkinensis 7.1 wt. %, radix angelicae dahuricae 7.1 wt. %, rhizoma paridis 7.l wt. %, herba artemisiae annuae 7.2 wt. %, and rhizoma iridis tectoris 7.2 wt. %. This Chinese traditional medicine composition could be made into any regular medicinal types, for example, oral solutions, tablets, capsules, pellets and injection solution, etc. Modified preparation methods for this Chinese traditional medicine composition, as well as the use of the same in preparation of medicines and health foods for prevention or treatment of avian influenza were also provided in present invention. This Chinese traditional medicine composition could effectively prevent and treat avian influenza.
    Type: Application
    Filed: January 19, 2007
    Publication date: July 26, 2007
    Inventors: Desheng Tao, Yongqing Zeng, Hui Cao, Yi Guan
  • Publication number: 20060110473
    Abstract: The invention discloses a composition containing radix Codonopsis pilosulae and radix Astragali and hedysari, The main component is made from radix Codonopsis pilosulae and radix Astragali and hedyyari in certain rate. The invention also discloses the method of producing it and the use for producing immune system-regulated agent and these medicaments for treatment of ischemic heart disease or acute pulmonary damage.
    Type: Application
    Filed: January 16, 2004
    Publication date: May 25, 2006
    Applicant: Li Min Pharmaceutical Factory Of Livzon Pharmaceutical
    Inventors: Weihong Xie, Desheng Tao, Chunhan Zhi